A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials.

ABSTRACT:

SUBMITTER: Fleischer A 

PROVIDER: S-EPMC10587328 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature